Effect of thyroid hormone supplementation on survival of euthyroid dogs with congestive heart failure due to systolic myocardial dysfunction: A double-blind, placebo-controlled trial

Research in Veterinary Science

Volumn 75, Issue 3, 2003, Pages 195-201

  Tidholm, Anna ^a   Falk, T ^b   Gundler, S ^c   Svensson, H ^d   Ablad B ^e   Sylven C ^f  

^a Albano Animal Hospital of Stockholm   (Sweden)

^b Helsingborg Animal Hospital   (Sweden)

^c Bagarmossen Referral Animal Hospital   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Blå Stjarnan Animal Hospital   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Canine; Cardiac therapy; Dilated cardiomyopathy; Thyroxine; Blocker

Indexed keywords

ALPRENOLOL; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM SENSITIZER; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; LEVOTHYROXINE SODIUM; PHOSPHODIESTERASE INHIBITOR; PLACEBO; PRACTOLOL; PROPRANOLOL; THYROID HORMONE; THYROTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; AUTOPSY; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOG DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EUTHANASIA; EUTHYROIDISM; FEMALE; HEART DILATATION; HEART INFARCTION; HEART MUSCLE CELL; HISTOPATHOLOGY; HORMONAL THERAPY; MALE; NONHUMAN; RADIOCARDIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SUDDEN DEATH; SURVIVAL TIME; THORAX RADIOGRAPHY; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VALVULAR HEART DISEASE;

CANIS FAMILIARIS; STAPHYLOCOCCUS PHAGE 187;

EID: 0141446422     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-5288(03)00111-5     Document Type: Article

References (36)

1. Anderson, J.L., Gilbert, E.M., O'Connell, J.B., Renlund, D., Yanowitz, F., Muray, M., Roskelly, M., Mealey, P., Volkman, K., Deitman, D., 1991. Long-term (2 year) beneficial effect of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology 17, 1373-1381.
2. Borgarelli, M., Tarducci, A., Bussadori, C., Santilli, R.A., Priano, L., 1997. Echocardiographic and echoDoppler prognostic indicators in dogs with dilated cardiomyopathy. In: ESVIM 7th Annual Congress, Lyon, France, pp. 25-28.
3. Borgarelli, M., Tarducci, A., Tidholm, A., Häggström, A., 2001. Canine idiopathic dilated cardiomyopathy. Part II: Pathophysiology and therapy. The Veterinary Journal 162, 182-185.
4. Bough, E.W., Crowley, W.F., Ridgway, E.C., Walker, H., Maloof, F., Myers, G.S., Daniels, G.H., 1978. Myocardial function in hypothyroidism. Relation to disease severity and response to treatment. Archives of Internal Medicine 138, 1476-1480.
5. Bristow, M.R., Ginsburg, R., Fowler, M., Minobe, W., Rasmussen, R., Zera, P., Menlove, R., Shah, P., Jamieson, S., 1986. β1 and β2 adrenergic receptor subpopulations in normal and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1 receptor down-regulation in heart failure. Circulation Research 59, 297-309.
6. Chastian, C.B., Panciera, D.L., 1995. Hypothyroid diseases. In: Ettinger, S.J. (Ed.), Textbook of Veterinary Internal Medicine, fourth ed. W.B. Saunders, Philadelphia, pp. 1487-1500.
7. Dillmann, W.H., 1984. Hormonal influence on cardiac myosin isoenzyme distribution. Molecular Cell Endocrinology 34, 161-181.
8. Ettinger, S.J., Benitz, A.M., Ericsson, G.F., Cifelli, S., Jernigan, A.D., Longhofer, S.L., Trimboli, W., Hanson, P.D., 1998. Effects of enalapril maleate on survival of dogs. with naturally occurring acquired heart failure. Journal of the American Veterinary Medical Association 213, 1573-1577.
9. Grossman, W., Robin, N.I., Johnson, L.W., Brooks, H.L., Selenkow, H.A., Dexter, L., 1971. The enhanced myocardial contractility of thyrotoxicosis. Role of the beta adrenergic receptor. Annals of Internal Medicine 74, 869-874.
10. Heidenreich, P.A., Lee, T.T., Massie, B.M., 1997. Effects of beta blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. Journal of the American College of Cardiology 30, 27-34.
11. Huang, F., He, H., Gick, G., 1994. Thyroid hormone regulation of Na,K-ATPase alpha 2 gene expression in cardiac myocytes. Cell and Molecular Biology Research 40, 41-52.
12. Klein, I., 1990. Thyroid hormone and the cardiovascular system. American Journal of Medicine 88, 631-637.
13. Klein, I., Ojamaa, K., 1996. Thyroid hormone and the heart. American Journal of Medicine 101, 459-460.
14. Ladenson, P., Bloch, K., Seidman, J., 1988. Modulation of atrial natriuretic factor by thyroid hormone: messenger ribonucleic acid and peptide levels in hypothyroid, euthyroid and hyperthyroid rat atria and ventricles. Endocrinology 123, 652-657.
15. Ladenson, P.W., 1990. Recognition and management of cardiovascular disease related to thyroid dysfunction. American Journal of Medicine 88, 638-641.
16. Limas, C., 1978. Calcium transport ATPase of cardiac sarcoplasmic reticulum in experimental hypothyroidism. American Journal of Physiology 235, 745-752.
17. Magyar, C.E., Wang, J., Azuma, K.K., McDonough, A.A., 1995. Reciprocal regulation of cardiac Na, K-ATPase and Na/Ca exchanger: hypertension, thyroid hormone, development. American Journal of Physiology 269, 675-682.
18. Moise, N., 1988. Echocardiography. In: Fox, P.R. (Ed.), Canine and Feline Cardiology. Churchill and Livingstone, New York, pp. 113-156.
19. Monnet, E., Orton, C., Salman, M., Boon, J., 1995. Idiopathic dilated cardiomyopathy in dogs: survival and prognostic indicators. Journal of Veterinary Internal Medicine 9, 12-17.
20. Moruzzi, P., Doria, E., Agostoni, P.G., Capacchione, V., Sganzerla, P., 1994. Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy. American Journal of Cardiology 73, 374-378.
21. Murchinson, L.E., Bewsher, P.D., Chesters, M.I., Ferrier, W.R., 1976. Comparison of propranolol and practolol in management of hyperthyroidism. British Journal of Clinical Pharmacology 3, 273-277.
22. Packer, M., Bristow, M.R., Cohn, J.N., Colucci, W.S., Fowler, M.B., Gilbert, E.M., Shusterman, N.H., 1996. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. New England Journal of Medicine 334, 1349-1355.
23. Panciera, D.L., Keene, B.W., Mier, H.C., 1992. Administration of levothyroxine to euthyroid dogs does not affect echocardiographic and electrocardiographic measurements. Research in Veterinary Science 53, 130-132.
24. Parker, J.L., Adams, H.R., 1977. Drugs and the heart muscle. Journal of the American Veterinary Medical Association 171, 78-84.
25. Rush, J.E., Freeman, L.M., Hiler, C., Brown, D.J., 2002. Use of metoprolol in dogs with acquired cardiac disease. Journal of Veterinary Cardiology 4, 23-27.
26. Rutherford, J.D., Vatner, S.F., Braunwald, E., 1979. Adrenergic control of myocardial contractility in conscious dogs. American Journal of Physiology 237, 590-596.
27. Sahn, D.J., De Maria, A., Kisslo, J., Weyman, A., 1978. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58, 1072-1083.
28. Sisson, D., O'Grady, M.R., Calvert, C.A., 1999. Myocardial diseases of dogs. In: Fox, P.R., Sisson, D., Moise, N.S. (Eds.), Textbook of Canine and Feline Cardiology: Principles and Clinical Practice. W.B. Saunders, Philadelphia, pp. 581-619.
29. The Bench (Benazepril in canine heart disease) study group, 1999. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled long-term clinical trial. Journal of Veterinary Cardiology 1, 7-17.
30. Thomas, W.P., Gaber, C.E., Jacobs, G.J., Kaplan, P.M., Lombard, C.W., Moise, N.S., Moses, B.L., 1993. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Journal of Veterinary Internal Medicine 7, 247-252.
31. Tidholm, A., Häggström, J., Borgarelli, M., Tarducci, A., 2001. Canine idiopathic dilated cardiomyopathy. Part I: Aetiology, clinical characteristics, epidemiology and pathology. The Veterinary Journal 162, 92-107.
32. Tidholm, A., Häggström, J., Jönsson, L., 1998. Prevalence of attenuated wavy fibers in the myocardium of dogs with dilated cardiomyopathy. Journal of the American Veterinary Medical Association 212, 1732-1734.
33. Tidholm, A., Jönsson, L., 1997. A retrospective study of canine dilated cardiomyopathy (189 cases). Journal of the American Animal Hospital Association 33, 544-550.
34. Tidholm, A., Svensson, H., Sylvén, C., 1997. Survival and prognostic factors in 189 dogs with dilated cardiomyopathy. Journal of American Animal Hospital Association 33, 364-368.
35. Tilley, L.P., 1985. Essentials of Canine and Feline Electrocardiography, second ed. Lea & Febiger, Philadelphia. pp. 58-75.
36. Waagstein, F., Hjalmarson, Å., Varnauskas, E., Wallentin, I., 1975. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. British Heart Journal 37, 1022-1036.